PATHWAY CAPITAL MANAGEMENT, LP - Q4 2022 holdings

$56 Million is the total value of PATHWAY CAPITAL MANAGEMENT, LP's 6 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 166.7% . PATHWAY CAPITAL MANAGEMENT, LP is a registered-investment adviser.

 Value Shares↓ Weighting
DAWN BuyDAY ONE BIOPHARMACEUTICALS I$21,427,163
+165.4%
995,686
+147.0%
38.24%
+47.7%
 TOAST INCcl a$21,074,744
-5.3%
1,168,8710.0%37.61%
-47.2%
NewARCELLX INC$5,858,938189,120
+100.0%
10.46%
AVEO NewAVEO PHARMACEUTICALS INC$3,671,810245,606
+100.0%
6.55%
TDG NewTRANSDIGM GROUP INC$2,852,3154,530
+100.0%
5.09%
FLYW NewFLYWIRE CORPORATION$1,149,11146,960
+100.0%
2.05%
ExitDUOLINGO INC$0-9,236
-100.0%
-2.82%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-02-10
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
TOAST INC6Q3 202371.3%
DATADOG INC6Q2 202224.7%
DYNATRACE INC4Q3 2020100.0%
ROBLOX CORPORATION4Q1 202247.1%
CROWDSTRIKE HOLDINGS INC4Q3 202320.3%
Amplitude, Inc.4Q3 20239.0%
BILL.COM HOLDINGS INC3Q1 202250.4%
DAY ONE BIOPHARMACEUTICALS I3Q4 202238.2%
QUANTERIX CORP3Q3 202117.8%
AIRBNB INC3Q3 20239.0%

View PATHWAY CAPITAL MANAGEMENT, LP's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-08
13F-HR2023-11-06
13F-HR2023-08-03
13F-HR2023-05-10
13F-HR2023-02-10
13F-HR2022-11-09
13F-HR2022-08-10
13F-HR2022-05-10
13F-HR2022-02-10
13F-HR2021-11-12

View PATHWAY CAPITAL MANAGEMENT, LP's complete filings history.

Compare quarters

Export PATHWAY CAPITAL MANAGEMENT, LP's holdings